We determined sources of activator calcium for prostanoid-induced cerebrovascular constriction by measuring isometric tension and calcium-45 ("Ca) fluxes in bovine middle cerebral arteries. Constriction induced by prostaglandin F^ or the stable thromboxane A 2 analogue SQ-26,655 was near-maximally inhibited in calcium-deficient solutions but only partially inhibited by calcium antagonists (10~! M verapamil or 33xlO~7 M nifedipine). Studies of ^Ca binding at different external Ca 2+ concentrations showed that cerebral arteries possess two calcium binding sites, a high-affinity site and a low-affinity site. Each prostanoid significantly increased low-affinity ^Ca uptake (external Ca 2+ concentration = 1.2 mmol/l) during 5 minutes of '"Ca loading; for prostaglandin F^ ^Ca uptake increased from 69 to 108 nmol/g and for SQ-26,655, from 78 to 141 nmol/g. The prostanoid-induced increases in low-affinity ^Ca uptake were completely abolished by pretreatment with verapamil or nifedipine. Prostaglandin F^, SQ-26,655, verapamil, and nifedipine had no effect on high-affinity ^Ca uptake (external Ca J+ concentration=45 /umol/l) or ^Ca efflux (after 60 minutes' preincubation in calcium-deficient media). Prostaglandin F^ and SQ-26,655 each appear to constrict cerebral arteries by two mechanisms: first, by promoting calcium uptake from low-affinity binding sites through receptor-operated channels sensitive to the calcium antagonists, and second, by releasing calcium from depletable internal stores. (Stroke 1991;22:66-72) 
Effects of Prostaglandin
We determined sources of activator calcium for prostanoid-induced cerebrovascular constriction by measuring isometric tension and calcium-45 ("Ca) fluxes in bovine middle cerebral arteries. Constriction induced by prostaglandin F^ or the stable thromboxane A 2 analogue SQ-26,655 was near-maximally inhibited in calcium-deficient solutions but only partially inhibited by calcium antagonists (10~! M verapamil or 33xlO~7 M nifedipine). Studies of ^Ca binding at different external Ca 2+ concentrations showed that cerebral arteries possess two calcium binding sites, a high-affinity site and a low-affinity site. Each prostanoid significantly increased low-affinity ^Ca uptake (external Ca 2+ concentration = 1.2 mmol/l) during 5 minutes of '"Ca loading; for prostaglandin F^ ^Ca uptake increased from 69 to 108 nmol/g and for SQ-26,655, from 78 to 141 nmol/g. The prostanoid-induced increases in low-affinity ^Ca uptake were completely abolished by pretreatment with verapamil or nifedipine. Prostaglandin F^, SQ-26,655, verapamil, and nifedipine had no effect on high-affinity ^Ca uptake (external Ca J+ concentration=45 /umol/l) or ^Ca efflux (after 60 minutes' preincubation in calcium-deficient media). Prostaglandin F^ and SQ-26,655 each appear to constrict cerebral arteries by two mechanisms: first, by promoting calcium uptake from low-affinity binding sites through receptor-operated channels sensitive to the calcium antagonists, and second, by releasing calcium from depletable internal stores. (Stroke 1991; 22:66-72) V asoconstrictor prostanoids such as thromboxane A 2 (TxA 2 ) or prostaglandin F^ (PGF^) have been implicated in the pathogenesis of many cerebrovascular disorders including stroke, postischemic hypoperfusion after cardiac arrest, and cerebral vasospasm after subarachnoid hemorrhage. 1 " 4 Both TxA 2 (released from aggregating platelets) and PGF^ are potent constrictors of human cerebral arteries. 5 " 9 Thromboxane R, (TxBJ, the stable metabolite of TxA 2 , and PGF^ rapidly accumulate in brain tissue after cerebral ischemia. 12 "
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Organic calcium antagonists (CAts) have been used in clinical settings to confer cerebral protection after stroke or cerebral vasospasm following sub-arachnoid hemorrhage. 1517 However, the ability of CAts to improve cerebral blood flow in these cerebrovascular disorders may be limited if vasoactive agents such as TxA 2 or PGF^ are involved in their pathogenesis. 17 ' 18 Prostanoid-induced constriction of isolated cerebral arteries is calcium-dependent but is partially resistant to inhibition by CAts such as nifedipine, 5 nimodipine, 58 ' 19 nicardipine, 20 -21 diltiazem, 22 or flunarizine. 23 The mechanism of resistance to CAts is not known. If CAts inhibit prostanoid-induced Ca 2+ uptake through CAt-sensitive channels in cerebrovascular smooth muscle, 24 then CAt-resistant constriction could be due to Ca 2+ uptake through CAt-insensitive channels, Ca 2+ release from intracellular stores such as the sarcoplasmic reticulum, or other mechanisms.
The purpose of this study was to identify the sources of activator calcium by which TxA 2 and PGF2,, constrict cerebral arteries. Isolated bovine middle cerebral arteries were cut into rings to measure isometric tension or into strips to measure calcium-45 ( tassium-induced constriction and 45 Ca uptake in cerebral arteries. 25 The 45 Ca from ICN Radiochemicals (Costa Mesa, Calif.), and [ 3 H]sorbitol from New England Nuclear (Boston, Mass.). Concentrated solutions of the agents were prepared with deionized water, except for nifedipine, which was solubilized in dimethyl sulfoxide (DMSO) (57 ^g nifedipine/ml DMSO), and SQ-26,655, which was dissolved in ethanol and diluted with 0.125 M NaCl. At the concentrations used, no solvent induced changes in isometric tension. Solutions were freshly prepared; foil-wrapped containers served to prevent light degradation.
For the isometric tension experiments, arteries were cut into rings of uniform width (2.5 mm). Each ring was mounted vertically on two L-shaped stainless steel wire holders (0.4 mm o.d.) between a glass anchor and a Statham isometric transducer (Glen Burnie, Md.). The rings were maintained in 25-50 ml oxygenated physiologic solution (37°C, pH=7.4) over a 2-3-hour equilibration period. Resting tension was gradually increased to 0J5 g, which was optimal for the arteries. 25 The development of isometric tension was recorded on digital readout amplifiers and on Kipp and Zonen Model BD40 (Bohemia, N.Y.) and Gould Brush Model 816 (Glen Burnie, Md.) recorders.
For all 45 Ca flux experiments, the arterial rings were opened into strips approximately 1.5 cm long. Each strip was quickly blotted on filter paper, weighed, and mounted on a stainless steel wire holder. After 3 hours' equilibration in a physiologic solution at 37°C, the strips were exposed to radioactive media ( [5. 5xlO~6 M]). After incubation in the radioactive media at 37°C, the strips were blotted with a Kimwipe tissue (Kimberly-Clark Corp., Roswell, Ga.), dipped momentarily in a calcium-deficient solution at 37°C, blotted again, and immersed in 50 ml ice-cold calcium-deficient solution containing 2 mM EGTA for 40 minutes. 25 The strips were incubated overnight in 3 ml of 0.1N HN0 3 + 1% LaCl 3 at 25°C to extract retained 45 Ca. Aliquots of the radioactive media, the calcium-deficient 2 mM EGTA solution, and the HNO 3 solution were added to 10 ml Scintiverse II scintillation cocktail (Fisher Scientific Co., Pittsburgh, Pa.) in 20-ml polyethylene vials, which were counted for 45 Ca and 3 H cpm in a Packard Tricarb liquid scintillation counter (Meriden, Conn.). Samples and blanks had equal volumes, so the raw counts required no quench correction.
In the 45 Ca uptake experiments, the total 45 Ca content of each strip (as micromoles per gram wet weight) was determined by adding the EGTA-extractable '"Ca content (i.e., that extracted from the strip into the EGTA solution) and the residual 45 Ca content (i.e., that remaining in the HNO 3 45 Ca content for each strip equaled its EGTA-extractable 45 Ca content minus the 45 Ca content of extracellular water in the EGTA solution. The 45 Ca uptake equaled the residual 45 Ca content minus the 45 Ca content of extracellular water in the HNO 3 solution.
For the 45 Ca efflux experiments, after 3 hours' equilibration the strips were incubated in radioactive media at 37°C for 60 minutes. The strips were blotted and dipped as previously described and immersed in a series of 3-ml aliquots of calcium-deficient 2 mM EGTA solution at 37°C over 2 hours. 25 Some strips were exposed to calcium-deficient 2 mM EGTA solution containing 10" 5 M PGF^ or 10" 8 M SQ-26,655 during the second hour. All strips were then incubated overnight in 3 ml of 0.1N HNO 3 + 1 % LaCl 3 at 25°C to extract residual calcium. The data obtained were expressed as desaturation curves (which demonstrate the decline of strip 45 Ca content with time) and as curves showing the fractional rate of 45 Ca efflux (percentage of 45 Ca lost per minute). 23 In all experiments, arterial rings or strips were selected at random to receive a drug or special treatment. Data are expressed as mean+SEM, with n^6 rings or strips from at least five different animals for each variable. The null hypothesis was examined using analysis of variance and the Newman-Keuls multiplerange t test and was rejected at/?<0.05. Calculations and statistical analyses were performed on microcomputers (Tandy TRS-80 Models III and IV, Fort Worth, Tex.) with BASIC or PHARM/PCS programs. When arterial rings were pretreated for 45 minutes with verapamil, nifedipine, or calcium-deficient solution, subsequent prostanoid-induced constriction was inhibited in a noncompetitive manner (Figure 1 ). Verapamil (10~5 M) or nifedipine (3.3 xlO" 7 M) in concentrations sufficient to produce near-maximal inhibition of K + -induced constriction of bovine cerebral arteries 25 produced only half-maximal inhibition of prostanoid-induced constriction. Pretreatment with verapamil caused maximal PGF^ and SQ-26,655-induced constriction to be reduced to 45.0±7.2% and 42.6+5.8% of control, respectively. Pretreatment with nifedipine caused maximal PGF^-and SQ-26,655-induced constriction to be reduced to 49.9±7.3% and 46.6±7.6% of control, respectively.
Exposure to calcium-deficient solution produced near-maximal inhibition of prostanoid-induced constriction, as is the case for K + -and serotonin-induced constriction of bovine cerebral arteries. 25 The PGF^-and SQ-26,655-induced constrictions were reduced to 15.5+2.2% and 7.7±1.5% of control, respectively. Each prostanoid also produced slight constriction in calcium-deficient potassium-rich solution (Figure 1) .
For the Ca 2+ dose-response curve experiments, arteries were first pretreated with calcium-deficient solution for 45 minutes, with vasoconstrictors for 30 minutes, and with CAts for an additional 30 minutes before Ca 2+ was added. Verapamil and nifedipine had no effect on SQ-26,655-induced constriction in calcium-deficient solutions. These CAts did produce slight (/?<0.05) relaxation of arteries preconstricted with PGF^ in calcium-deficient solutions; control tension decreased 0.06+0.02 g, while tension de- Calcium produced dose-dependent constriction when it was restored to calcium-deficient solutions containing PGF^ or SQ-26,655 (Figure 2 ). Verapamil and nifedipine inhibited the subsequent Ca 2+ -induced vasoconstriction in a competitive manner. The CAts caused the Ca 2+ dose-response curve to be shifted to the right, although significant constriction still occurred at Ca 2+ concentrations between 10~4 and 10" 3 M. To determine the effects of external Ca 2+ concentration on 45 Ca uptake and contents, arterial strips were incubated for 60 minutes in radioactive media containing no EGTA and various concentrations of Ca 2+ (from 15 to 3,000 fisnoVl). The concentrations of Ca 2+ in the incubating solutions were confirmed with atomic absorption spectrophotometry. The uptake of 45 Ca was dependent on the extracellular Ca 2+ concentration ( Figure 3) solutions (Figure 3) . The use of a Scatchard plot of bound 45 Ca content 30 -32 showed that bovine cerebral arteries possess two distinct (high-and low-affinity) calcium binding sites (Figure 4) . The x-axis intercept yields an estimate of the number of high-or lowaffinity sites on smooth muscle, while the affinity of each site can be expressed in terms of the apparent dissociation constant, K d , where K a equals the x-axis intercept divided by the _y-axis intercept. 32 Based on the x-axis intercept values (4.63 and 0.47 jimol/g), low-affinity calcium binding sites outnumber highaffinity binding sites by approximately 10:1.
Both PGF^ and SQ-26,655 increased 45 Ca uptake into bovine cerebral arteries during 5 minutes of 45 Ca loading when the external Ca 2+ concentration was 1.2 mmol/1 ( Figure 5 ); this 45 Ca influx represents uptake from low-affinity sites on the arteries. For PGF^, 45 Ca uptake increased from 69 to 108 nmol/g, and for SQ-26,655, from 78 to 141 nmol/g. Verapamil and nifedipine significantly blocked the increase in 45 Ca uptake induced by PGF^ and SQ-26,655 ( Figure 5) ; the resultant 45 Ca uptake was not significantly greater than control. Verapamil and nifedipine had no significant effect on basal 45 Ca uptake. Used to solubilize nifedipine, DMSO had no effect on basal 45 Ca uptake or the 45 Ca uptake induced by PGF^ or SQ-26,655. Verapamil, P G F^ SQ-26,655, nifedipine, and DMSO had no effect on total 45 Ca content, total 45 Ca content or 45 Ca uptake, n=S strips per data point.
To determine if the agents had an effect on 45 Ca influx from high-affinity binding sites, 45 Ca influx was examined in radioactive media containing 45 /xM Ca 2+ (with no EGTA): Control high-affinity 45 Ca uptake was 15 ±1 nmol/g after 5 minutes of 4S Ca loading. Verapamil, DMSO, nifedipine, PGF^, SQ-26,655, and serotonin had no significant effect on high-affinity 45 Ca uptake. Only 144 mM K + (isosmotically substituted for Na + in the physiologic solution) increased high-affinity 45 Ca uptake (/><0.01); after 5 minutes K + -induced 45 Ca uptake was 25±3 nmol/g. Verapamil, nifedipine, DMSO, and the vasoconstrictors had no effect on total 45 Ca content, total [ In the 45 Ca efflux studies, exposure to calciumdeficient 2 mM EGTA solution at 37°C produced a time-dependent reduction in 45 Ca content. 25 After the arteries were exposed to the calcium-deficient EGTA solution for 60 minutes, PGF^ (1(T 3 M) and SQ-26,655 (10~8 M) had no effect on the rate of 45 Ca efflux.
Discussion
Vascular smooth muscle contraction depends on an increase in free cytoplasmic calcium. 33 - 34 The Ca 2+ for constriction is supplied from two main sources, the extracellular space and the sarcoplasmic reticulum. 
Extracellular Ca
2+ can enter the cytoplasm through three different channels in the plasma membrane: voltage-dependent channels, receptor-operated channels, and leak-operated channels. 34 In high concentrations, K + depolarizes the plasma membrane of cerebral arteries and promotes Ca 2+ influx through voltage-dependent channels. 42 Extracellular Ca 2+ can also passively cross the plasma membrane in the absence of excitation through leak-operated channels. 34 Organic CAts inhibit vascular constriction mainly by blocking Ca 2+ uptake through voltage-dependent channels, specifically the long-lasting or slow (L) calcium channels.
-
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- 43 The CAts also block Ca 2+ uptake through receptor-operated channels to a variable extent, depending on the blood vessel studied and the pharmacologic agent used to produce constriction. 15,17,43 Drug competition and radioligand binding studies suggest that the four classes of CAts -the dihydropyridines (e.g., nifedipine, nimodipine, and nicardipine), the phenylalkylamines (e.g., verapamil), the benzothiazepines (e.g., diltiazem), and the piperazines (e.g., flunarizine and lidoflazine) - The present study demonstrates that PGF^ and SQ-26,655 each constrict cerebral arteries in part by promoting the influx of extracellular Ca 2+ through CAt-sensitive receptor-operated channels. When bovine middle cerebral arteries were pretreated with the CAts nifedipine and verapamil in concentrations sufficient to produce near-maximal inhibition of K + -induced constriction, 25 subsequent maximal PGF^-or SQ-26,655-induced constriction was reduced by approximately 50% (Figure 1 ). When Ca 2+ was restored to calcium-deficient solutions containing PGF^ or SQ-26,655 and either verapamil or nifedipine, Ca 2+ -induced constriction was inhibited in a competitive manner (Figure 2 ). Both PGF^ and SQ-26,655 increased "*Ca uptake, and the increases in uptake were blocked by verapamil and nifedipine ( Figure 5 ).
The bulk of extracellular calcium in vascular smooth muscle does not exist as free Ca 2+ but is bound to abundant anionic sites on the plasma membrane and the interstitium between muscle cells. 27 This study demonstrates that cerebral arteries possess two distinct calcium binding sites, a highaffinity site and a low-affinity site (Figure 4) . Peripheral vessels also have two distinct calcium binding sites. 31 - 32 Such binding sites may be located within the glycocalyx or on the outer membrane surface of vascular smooth muscle. 45 In bovine cerebral arteries, low-affinity binding sites outnumber high-affinity sites by approximately 10:1. Both PGF^ and SQ-26,655 stimulate 45 Ca uptake into the arteries from low-affinity binding sites ( Figure 5 ), as do K + and serotonin 25 ; low-affinity sites predominate when the free extracellular Ca 2+ concentration is 1.2 mM. As is the case with human cerebral arteries, 5 ' 8 prostanoid-induced constriction of bovine middle cerebral arteries is partially resistant to inhibition by CAts. This CAt-resistant constriction is dependent on Ca 2+ in the external media (Figures 1 and 2) . The contractility studies suggest that PGF^ and SQ-26,655 promote Ca 2+ influx through CAt-insensitive channels, but the 45 Ca flux studies do not support this hypothesis. The 45 Ca uptake from low-affinity binding sites stimulated by PGF^ and SQ-26,655 was completely blocked by verapamil and nifedipine ( Figure  5 ). These prostanoids had no effect on 45 Ca uptake from high-affinity binding sites. Only K + increased 45 Ca uptake from high-affinity binding sites, as is the case in peripheral vascular smooth muscle. 47 Each prostanoid produces some constriction in calcium-deficient solutions (Figure 1) , indicative of internal Ca 2+ release. The intracellular store is depleted when Ca 2+ influx is blocked, so prostanoid-induced constriction is inhibited to a greater extent by calcium withdrawal than by CAts. The store is replenished by extracellular Ca 2+ entering through leak-operated channels, so Ca 2+ constricts arteries when it is restored to calciumdeficient solutions containing PGF^ or SQ-26,655, even when CAts are present (Figure 2) . Exposure of arteries to calcium-deficient solutions inhibits basal (leak-operated) 45 Ca uptake (Figure 3) , while verapamil and nifedipine have no effect on basal 4S Ca uptake from either high-or low-affinity binding sites ( Figure 5 ). Agents that release Ca 2+ from intracellular stores would be expected to increase the rate of 45 Ca efflux, as is the case for two TxA 2 analogues acting on isolated rabbit aorta and human vessels. 36 ' 41 Neither PGF^ nor SQ-26,655 increased 45 Ca efflux from bovine cerebral arteries, most likely because 45 Ca was depleted from the intracellular stores by exposure to calcium-deficient 2 mM EGTA solution for 60 minutes. Under similar conditions, PGF^ also failed to stimulate 45 Ca efflux from bovine coronary arteries. 48 An increase in 45 Ca efflux may be undetectable by the present methodology, or Ca 2+ may translocate from one intracellular store to another. 25 Accordingly, CAts may be limited in their ability to improve cerebral blood flow in cerebrovascular disorders such as stroke, postischemic hypoperfusion after cardiac arrest, or cerebral vasospasm after subarachnoid hemorrhage if PGF^ or TxA 2 is involved in the pathogenesis of these disorders.
